EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The end of the genetic paradigm of cancer

Sui Huang iD, Ana M Soto iD, Carlos Sonnenschein

PLOS Biology · 18.03.2025 · 23 (3) · e3003052

DOI: 10.1371/journal.pbio.3003052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Biology, online erschienen am 18.03.2025. Verfasst von Sui Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Systems Biology, Seattle, Washington, United States of America. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome sequencing of cancer and normal tissues, alongside single-cell transcriptomics, continues to produce findings that challenge the idea that cancer is a ‘genetic disease’, as posited by the somatic mutation theory (SMT). In this prevailing paradigm, tumorigenesis is caused by cancer-driving somatic mutations and clonal expansion. However, results from tumor sequencing, motivated by the genetic paradigm itself, create apparent ‘paradoxes’ that are not conducive to a pure SMT. But beyond genetic causation, the new results lend credence to old ideas from organismal biology. To resolve inconsistencies between the genetic paradigm of cancer and biological reality, we must complement deep sequencing with deep thinking: embrace formal theory and historicity of biological entities, and (re)consider non-genetic plasticity of cells and tissues. In this Essay, we discuss the concepts of cell state dynamics and tissue fields that emerge from the collective action of genes and of cells in their morphogenetic context, respectively, and how they help explain inconsistencies in the data in the context of SMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansMutationAnimalsCarcinogenesis

Autor:innen und Institutionen

  • Institute for Systems Biology, Seattle, Washington, United States of America.
  • Tufts University School of Medicine, Immunology, Boston, Massachusetts, United States of America.

ORCID-Profile: Sui Huang, Ana M Soto

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institute of Environmental Health Sciences
  • Cancer Research UK, Cancer Grand Challenge
  • John Templeton Foundation
  • EU Horizon 2020 Research and Innovation programme

Zitieren

APA

Huang, S., Soto, A. M., & Sonnenschein, C. (2025). The end of the genetic paradigm of cancer. PLOS Biology, 23(3), e3003052. https://doi.org/10.1371/journal.pbio.3003052

Vancouver

Huang S, Soto AM, Sonnenschein C. The end of the genetic paradigm of cancer. PLOS Biology. 2025;23(3):e3003052. doi:10.1371/journal.pbio.3003052

BibTeX
@article{Huang2025,
  author = {Huang, Sui and Soto, Ana M and Sonnenschein, Carlos},
  title = {The end of the genetic paradigm of cancer},
  journal = {PLOS Biology},
  year = {2025},
  volume = {23},
  number = {3},
  pages = {e3003052},
  doi = {10.1371/journal.pbio.3003052}
}
Kostenlos starten →